The world's largest derivatives exchange is about to take the world's most important derivatives regulator to federal court. CME Group CEO Terrence Duffy announced on CNBC on June 17 that CME will sue the Commodity Futures Trading Commission over its May 29 approval of perpetual futures contracts for US markets - specifically Kalshi's BTCPERP product and Coinbase's offshore Deribit routing.
CME's argument is straightforward and grounded in statutory text: perpetual contracts are swaps, not futures. Under the Dodd-Frank Wall Street Reform Act of 2010, when two parties exchange periodic payments to each other - which is exactly what the funding-rate mechanism in perpetual contracts does - that instrument is classified as a swap. Swaps face an entirely different regulatory framework than futures, including swap dealer registration, higher margin requirements, and restrictions that would effectively limit them to institutional platforms.
"Under the Dodd-Frank Act, it clearly defines what a swap is and what a future is, and when there's two parties exchanging payments to each other, that's deemed a swap," Duffy told CNBC. The CFTC's response so far has been dismissive - a spokesperson called the planned lawsuit "frivolous." But CME doesn't file frivolous lawsuits. They spend over $240 billion a day clearing trades. They know derivatives law better than nearly anyone on the planet.
What CME is actually claiming
CME Group isn't making a vague philosophical argument about market structure. They're pointing at a specific section of a specific law and saying the CFTC is ignoring it.
The Commodity Exchange Act, as amended by Dodd-Frank, draws a clear line between futures and swaps. A future is a standardized contract to buy or sell an asset at a predetermined price on a specific future date. A swap is an agreement where two parties exchange periodic payments based on an underlying reference. The distinction matters because futures and swaps are regulated under completely different frameworks, with different capital requirements, different registration obligations, and different customer protections.
Perpetual futures contracts - "perps" in crypto shorthand - have no expiration date. Instead of settling at a future date like a traditional futures contract, they use a "funding rate" mechanism where long and short position holders make periodic payments to each other based on the difference between the perp price and the spot price. When the perp trades above spot, longs pay shorts. When it trades below, shorts pay longs. This mechanism keeps the perp price anchored to spot, but it also creates exactly the kind of periodic payment exchange that Dodd-Frank defines as a swap.
CME's position is that the CFTC can't simply call a swap a future because it has "futures" in its name. The economic substance of the instrument - periodic payments between counterparties with no fixed expiration - is what determines its regulatory classification, not the marketing label. And on those terms, CME argues, the law is clear.
The Dodd-Frank argument, explained
To understand why CME's lawsuit could actually succeed, you need to understand what Dodd-Frank was designed to do and how it defines these instruments.
Dodd-Frank was passed in 2010 in response to the 2008 financial crisis, which was caused in large part by unregulated swaps - specifically credit default swaps on mortgage-backed securities. The law created a comprehensive regulatory framework for swaps, including mandatory clearing, swap dealer registration, margin requirements, and reporting obligations. The entire point was to make sure complex derivative instruments couldn't accumulate systemic risk outside regulatory view again.
The law's definitions are specific. Title VII of Dodd-Frank defines a "swap" broadly to include any agreement that provides for "the exchange, on a fixed or contingent basis, of one or more payments based on the value or level of one or more rates, currencies, commodities, securities, instruments of indebtedness, indices, quantitative measures, or other financial or economic interests." The funding-rate payments in perpetual contracts fit this definition almost perfectly - they are periodic payments exchanged between parties based on the value difference between the contract price and the spot reference price.
The CFTC has historically had broad discretion in classifying instruments, and the agency clearly believes perps are close enough to futures to fall under its existing futures regulatory framework. But CME is betting that a federal court will look at the statutory text - not the CFTC's interpretation - and conclude that when Congress wrote a specific definition of a swap, instruments that match that definition don't get reclassified just because a regulator finds it convenient.
This is a textualist argument, and in the current federal court environment, textualist arguments tend to do well. Courts have been increasingly skeptical of agency interpretations that stretch beyond the plain language of statutes, especially since the Supreme Court's 2024 decision in Loper Bright Enterprises v. Raimondo, which overturned Chevron deference. Without Chevron, the CFTC can't simply argue that its interpretation of "swap" and "future" deserves judicial deference. The court will make its own determination of what the statute means.
What happens if CME wins
If a federal court agrees with CME that perpetual contracts are swaps under Dodd-Frank, the consequences would reshape crypto derivatives in the United States.
First, any platform offering perps in the US would need to register as a swap execution facility (SEF) or designated contract market with swap authority, not just as a futures exchange. The registration requirements are substantially more burdensome, more expensive, and more time-consuming.
Second, entities making markets in perps would likely need to register as swap dealers, triggering capital requirements, business conduct rules, and reporting obligations that most crypto-native firms aren't built to handle. The swap dealer registration process alone can take years and cost millions in compliance infrastructure.
Third, margin requirements for swaps are generally higher than for futures. Retail traders who currently access perps with 20x or 50x leverage on offshore platforms would face much stricter collateral requirements if those products were reclassified as swaps and offered through US-regulated channels.
Fourth - and this is the outcome crypto-native platforms fear most - swaps have historically been restricted to institutional participants. If perps are swaps, retail access could be severely limited or eliminated entirely on US-regulated platforms. The entire value proposition of bringing perps onshore for American retail traders could collapse.
The daily offshore perps market exceeds $50 billion in notional volume, making it the largest segment of crypto derivatives globally. If that volume can't be routed through US futures exchanges because the products are legally swaps, it stays offshore - which is arguably worse for US market integrity, not better.
The competitive angle CME won't talk about
There's a dimension to this lawsuit that CME won't put in the legal filings but that everyone in the industry understands: CME has its own Bitcoin futures products, and perpetual contracts are a direct competitive threat to them.
CME launched Bitcoin futures in December 2017 and has been the dominant regulated venue for institutional crypto derivatives ever since. Their standard BTC futures contract and the smaller Micro Bitcoin futures are among the most-traded crypto derivatives products in the world. CME makes money on every contract traded and every contract held through its clearinghouse.
Perpetual contracts are the most popular derivative product in all of crypto. On offshore exchanges, perps account for 60-70% of all crypto trading volume. If regulated US platforms can now offer perps - products that don't expire and that retail traders prefer because they don't require roll management - CME's traditional BTC futures face real competitive pressure for the first time.
That doesn't mean CME's legal argument is wrong. The Dodd-Frank text does say what CME says it says. But it does mean CME's motivations aren't purely about regulatory purity. They're protecting a business that generated over $5.6 billion in revenue last year and that trades at a $75 billion market cap. When the largest exchange in the world sues its own regulator, it's worth asking who benefits.
The counterargument is that CME could simply develop its own perpetual product. If perps are classified as futures, CME could list one tomorrow. The fact that they're suing to reclassify perps as swaps - which would make them harder for anyone to offer - suggests CME would rather keep the competitive threat off the table entirely than compete on product merit.
What traders should expect
This lawsuit will take time. Federal litigation moves slowly, and the legal questions involved are complex enough that they'll likely require extensive briefing, possibly expert testimony, and potentially appeals regardless of the initial ruling. Traders should plan for a resolution timeline measured in years, not months.
In the near term, the CFTC's approval of Kalshi's BTCPERP and Coinbase's Deribit routing stands. CME could seek an injunction to pause those approvals while the case proceeds, but injunctions in administrative law cases are hard to get. The standard requires showing likelihood of success on the merits, irreparable harm, and that the public interest favors the injunction - a high bar when the government is the defendant.
If you're trading on platforms that just received perps approval, those products should remain available during litigation. But the overhang of legal uncertainty could affect product development. Platforms that were planning to launch additional perp products may delay those launches until the legal picture clears. Institutional participants that were eyeing US-regulated perps may hold back until they know whether those products will be reclassified.
The broader market impact depends on whether this case stays isolated or triggers a wider re-examination of crypto derivatives classification. If other TradFi incumbents join CME's argument - either as amici in the lawsuit or through their own regulatory challenges - it could slow the integration of crypto-native products into US regulated markets by years.
For CME stock (ticker: CME, trading above $240), this is a watchlist event. A win would remove a competitive threat to CME's Bitcoin futures franchise. A loss would accelerate the arrival of perps on regulated US platforms and put pressure on CME to develop its own perpetual product to compete. Either way, the outcome will reshape the competitive landscape of crypto derivatives in America.
NOT INVESTMENT ADVICE. This article discusses regulatory and legal developments affecting cryptocurrency derivatives. Nothing in this piece constitutes a recommendation to buy, sell, or hold any security or derivative product. Consult a licensed attorney or financial advisor for guidance specific to your situation.
Frequently asked questions
What is CME Group suing the CFTC over?
CME Group is suing the CFTC over its May 29, 2026 approval of perpetual futures contracts for US markets. CME argues that perpetual contracts - which use a funding-rate mechanism involving periodic payments between long and short holders - are legally classified as swaps under the Dodd-Frank Act, not futures. The lawsuit targets the CFTC's approval of Kalshi's BTCPERP product and Coinbase's arrangement to route offshore Deribit trades.
What is a perpetual futures contract?
A perpetual futures contract (or "perp") is a derivative that tracks the price of an underlying asset without an expiration date. Unlike traditional futures that settle on a specific date, perps use a "funding rate" where long and short holders make periodic payments to each other to keep the contract price anchored to the spot market price. Perps are the most popular derivative product in crypto, accounting for 60-70% of trading volume on offshore exchanges.
Why does CME say perps are swaps, not futures?
CME's argument centers on Dodd-Frank's statutory definitions. The law defines a swap as an agreement involving the exchange of periodic payments between parties based on an underlying value. The funding-rate mechanism in perpetual contracts does exactly that - longs pay shorts (or vice versa) every eight hours based on the difference between the perp price and spot price. CME argues this periodic payment structure is the defining characteristic of a swap, regardless of what the product is called.
What did the CFTC say about CME's planned lawsuit?
A CFTC spokesperson called CME's planned legal action "frivolous." The CFTC maintains that its approval of perpetual futures falls within its regulatory authority and that perpetual contracts are properly classified under its existing futures framework.
What happens to perps trading in the US if CME wins?
If a federal court rules that perpetual contracts are swaps under Dodd-Frank, platforms offering them would need to register as swap execution facilities instead of futures exchanges. Market makers would need swap dealer registration. Margin requirements would increase significantly. Most importantly, swaps have historically been restricted to institutional participants, meaning retail traders could lose access to perps on US-regulated platforms entirely.
Is CME suing because perps compete with its own Bitcoin futures?
CME has its own Bitcoin futures products that generate significant revenue, and perpetual contracts offered on US-regulated platforms would be direct competitors. CME's legal argument has merit on the statutory text, but the competitive motivation is widely acknowledged in the industry. CME could theoretically develop its own perpetual product rather than trying to reclassify the entire instrument category as swaps.
How long will this lawsuit take?
Federal litigation of this complexity typically takes years. The case involves statutory interpretation, administrative law, and potentially novel questions about derivatives classification. Expect extensive briefing, possible expert testimony, and likely appeals regardless of the initial ruling. CME could seek a preliminary injunction to pause the CFTC's approvals during litigation, but such injunctions are difficult to obtain against the government.
Will Kalshi and Coinbase perps stay available during the lawsuit?
Yes, barring a successful injunction. The CFTC's approval stands until a court overturns it. However, the legal uncertainty may slow further product development and could cause institutional participants to delay entering the US perps market until the case is resolved.
How does the end of Chevron deference affect this case?
The Supreme Court's 2024 Loper Bright decision overturned Chevron deference, which previously required courts to defer to agency interpretations of ambiguous statutes. Without Chevron, the CFTC can't argue that its classification of perps as futures deserves automatic deference. The court will independently interpret the Dodd-Frank definitions, which favors CME's textualist argument.
What is the Dodd-Frank Act and why does it matter here?
The Dodd-Frank Wall Street Reform and Consumer Protection Act was passed in 2010 in response to the 2008 financial crisis, which was fueled partly by unregulated swaps. Title VII created a comprehensive regulatory framework for swaps including mandatory clearing, dealer registration, and margin requirements. The law's specific definitions of "swap" and "future" are the centerpiece of CME's lawsuit - they argue Congress drew a clear line that the CFTC is now ignoring.
Sean Ristau | @SeanRistau | 21Rates / The Daily Stack